These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
328 related articles for article (PubMed ID: 29545756)
61. Clinical Integration of Digital Solutions in Health Care: An Overview of the Current Landscape of Digital Technologies in Cancer Care. Garg S; Williams NL; Ip A; Dicker AP JCO Clin Cancer Inform; 2018 Dec; 2():1-9. PubMed ID: 30652580 [TBL] [Abstract][Full Text] [Related]
62. Mood Prediction of Patients With Mood Disorders by Machine Learning Using Passive Digital Phenotypes Based on the Circadian Rhythm: Prospective Observational Cohort Study. Cho CH; Lee T; Kim MG; In HP; Kim L; Lee HJ J Med Internet Res; 2019 Apr; 21(4):e11029. PubMed ID: 30994461 [TBL] [Abstract][Full Text] [Related]
63. Systematic review of context-aware digital behavior change interventions to improve health. Thomas Craig KJ; Morgan LC; Chen CH; Michie S; Fusco N; Snowdon JL; Scheufele E; Gagliardi T; Sill S Transl Behav Med; 2021 May; 11(5):1037-1048. PubMed ID: 33085767 [TBL] [Abstract][Full Text] [Related]
64. Application of artificial intelligence in wearable devices: Opportunities and challenges. Nahavandi D; Alizadehsani R; Khosravi A; Acharya UR Comput Methods Programs Biomed; 2022 Jan; 213():106541. PubMed ID: 34837860 [TBL] [Abstract][Full Text] [Related]
65. Wearable technology in epilepsy: The views of patients, caregivers, and healthcare professionals. Bruno E; Simblett S; Lang A; Biondi A; Odoi C; Schulze-Bonhage A; Wykes T; Richardson MP; Epilepsy Behav; 2018 Aug; 85():141-149. PubMed ID: 29940377 [TBL] [Abstract][Full Text] [Related]
66. Going digital: a narrative overview of the effects, quality and utility of mobile apps in chronic disease self-management. Scott IA; Scuffham P; Gupta D; Harch TM; Borchi J; Richards B Aust Health Rev; 2020 Feb; 44(1):62-82. PubMed ID: 30419185 [TBL] [Abstract][Full Text] [Related]
67. Effects of anxiety and mood disorders on craving and substance use among patients with substance use disorder: An ecological momentary assessment study. Fatseas M; Serre F; Swendsen J; Auriacombe M Drug Alcohol Depend; 2018 Jun; 187():242-248. PubMed ID: 29684892 [TBL] [Abstract][Full Text] [Related]
68. Digital Phenotyping With Mobile and Wearable Devices: Advanced Symptom Measurement in Child and Adolescent Depression. Sequeira L; Battaglia M; Perrotta S; Merikangas K; Strauss J J Am Acad Child Adolesc Psychiatry; 2019 Sep; 58(9):841-845. PubMed ID: 31445619 [TBL] [Abstract][Full Text] [Related]
69. Review: Application of Artificial Intelligence in Phenomics. Nabwire S; Suh HK; Kim MS; Baek I; Cho BK Sensors (Basel); 2021 Jun; 21(13):. PubMed ID: 34202291 [TBL] [Abstract][Full Text] [Related]
70. Identifying Behavioral Phenotypes of Loneliness and Social Isolation with Passive Sensing: Statistical Analysis, Data Mining and Machine Learning of Smartphone and Fitbit Data. Doryab A; Villalba DK; Chikersal P; Dutcher JM; Tumminia M; Liu X; Cohen S; Creswell K; Mankoff J; Creswell JD; Dey AK JMIR Mhealth Uhealth; 2019 Jul; 7(7):e13209. PubMed ID: 31342903 [TBL] [Abstract][Full Text] [Related]
71. Using smartphones to decrease substance use via self-monitoring and recovery support: study protocol for a randomized control trial. Scott CK; Dennis ML; Gustafson DH Trials; 2017 Aug; 18(1):374. PubMed ID: 28797307 [TBL] [Abstract][Full Text] [Related]
72. Digital Technologies in the Treatment of Anxiety: Recent Innovations and Future Directions. Firth J; Torous J; Carney R; Newby J; Cosco TD; Christensen H; Sarris J Curr Psychiatry Rep; 2018 May; 20(6):44. PubMed ID: 29779065 [TBL] [Abstract][Full Text] [Related]
73. A roadmap for implementation of patient-centered digital outcome measures in Parkinson's disease obtained using mobile health technologies. Espay AJ; Hausdorff JM; Sánchez-Ferro Á; Klucken J; Merola A; Bonato P; Paul SS; Horak FB; Vizcarra JA; Mestre TA; Reilmann R; Nieuwboer A; Dorsey ER; Rochester L; Bloem BR; Maetzler W; Mov Disord; 2019 May; 34(5):657-663. PubMed ID: 30901495 [TBL] [Abstract][Full Text] [Related]
74. A Framework for Competencies for the Use of Mobile Technologies in Psychiatry and Medicine: Scoping Review. Hilty D; Chan S; Torous J; Luo J; Boland R JMIR Mhealth Uhealth; 2020 Feb; 8(2):e12229. PubMed ID: 32130153 [TBL] [Abstract][Full Text] [Related]
75. Digital Technologies and Data Science as Health Enablers: An Outline of Appealing Promises and Compelling Ethical, Legal, and Social Challenges. Cordeiro JV Front Med (Lausanne); 2021; 8():647897. PubMed ID: 34307394 [TBL] [Abstract][Full Text] [Related]
76. Digital phenotyping for assessment and prediction of mental health outcomes: a scoping review protocol. Spinazze P; Rykov Y; Bottle A; Car J BMJ Open; 2019 Dec; 9(12):e032255. PubMed ID: 31892655 [TBL] [Abstract][Full Text] [Related]
77. Use of Ecological Momentary Assessment Through a Passive Smartphone-Based App (eB2) by Patients With Schizophrenia: Acceptability Study. Lopez-Morinigo JD; Barrigón ML; Porras-Segovia A; Ruiz-Ruano VG; Escribano Martínez AS; Escobedo-Aedo PJ; Sánchez Alonso S; Mata Iturralde L; Muñoz Lorenzo L; Artés-Rodríguez A; David AS; Baca-García E J Med Internet Res; 2021 Jul; 23(7):e26548. PubMed ID: 34309576 [TBL] [Abstract][Full Text] [Related]
78. Digital Phenotyping to Enhance Substance Use Treatment During the COVID-19 Pandemic. Hsu M; Ahern DK; Suzuki J JMIR Ment Health; 2020 Oct; 7(10):e21814. PubMed ID: 33031044 [TBL] [Abstract][Full Text] [Related]
79. Digital health and wearable devices for retinal disease monitoring. Daich Varela M; Sanders Villa A; Pontikos N; Crossland MD; Michaelides M Graefes Arch Clin Exp Ophthalmol; 2024 Sep; ():. PubMed ID: 39297890 [TBL] [Abstract][Full Text] [Related]